Case report: Application of non-VKA oral anticoagulants in patient of idiopathic hypereosinophilic syndrome with intracardiac thrombus

被引:2
|
作者
Zou, Man [1 ]
Liu, Geyan [2 ]
Li, Yanhui [2 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Oncol, Wuhan, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Internal Med, Wuhan, Peoples R China
基金
中国国家自然科学基金;
关键词
idiopathic hypereosinophilic syndrome; non-VKA oral anticoagulants; shortness of breath; heart failure; intracardiac thrombus; case report;
D O I
10.3389/fphar.2022.1018394
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Idiopathic hypereosinophilic syndrome (IHES) is a rare but life-threatening disease related to a group of myeloproliferative disorders characterized by prolonged eosinophilia of unknown cause and inflammatory damage to multiple organs. Here, we present a 44-year-old female patient complaining of shortness of breath and palpitations for 1 month. Her history and presentation were unremarkable, except for a 3-years history of rheumatoid arthritis treated with ibuprofen (0.3 g per day). Initial examination showed heart rate (HR) 120 bpm, respiratory rate (RR) 20 bpm, temperature (T) 36?, blood pressure (BP) 130/70 mmHg, ventricular gallop rhythm, rales at the lung bases, soft abdomen, nonpalpable liver and spleen, and slight edema in both lower extremities. Bone marrow aspirate and biopsy confirmed the diagnosis of IHES, while cardiac MRI showed intracardiac thrombus. The symptoms of shortness of breath and palpitation disappeared, the eosinophil counts in routine blood tests were normal, and the thrombus in the cardiac cavity gradually disappeared after combined therapy of anti-hypereosinophilic, anti-coagulant and anti-heart failure treatments.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Non-VKA oral anticoagulants: an update for the clinical biologists
    Mullier, Francois
    Douxfils, Jonathan
    Tamigniau, Anne
    Dogne, Jean-Michel
    Horellou, Marie-Helene
    Flaujac, Claire
    Chatelain, Bernard
    Goffinet, Catherine
    Samama, Meyer-Michel
    Gouin-Thibault, Isabelle
    ANNALES DE BIOLOGIE CLINIQUE, 2015, 73 (03) : 333 - 344
  • [2] Impact of non-VKA oral anticoagulants on AF ablation outcome
    Zweiker, D.
    Manninger, M.
    Ebner, J.
    Sieghartsleitner, R.
    Ohnewein, B.
    Bisping, E.
    Lercher, P.
    Prenner, G.
    Riedlbauer, R.
    Brussee, H.
    Scherr, D.
    WIENER KLINISCHE WOCHENSCHRIFT, 2017, 129 : S41 - S41
  • [3] Residual thrombus mass and incidence of post thrombotic syndrome in patients treated with VKA or non-VKA oral anticoagulants in phase-III DVT treatment trials
    Werth, S.
    Paternoga, I
    Tittl, L.
    Weiss, N.
    Beyer-Westendorf, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 434 - 434
  • [4] Non-VKA Oral Anticoagulants: Accurate Measurement of Plasma Drug Concentrations
    Douxfils, Jonathan
    Mani, Helen
    Minet, Valentine
    Devalet, Berangere
    Chatelain, Bernard
    Dogne, Jean-Michel
    Mullier, Francois
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [5] Venous thromboembolism in the elderly: Efficacy and safety of non-VKA oral anticoagulants
    Geldhof V.
    Vandenbriele C.
    Verhamme P.
    Vanassche T.
    Thrombosis Journal, 12 (1)
  • [6] Intravenous thrombolysis for stroke in patients taking non-VKA oral anticoagulants: an update
    Cappellari, Manuel
    Bovi, Paolo
    THROMBOSIS AND HAEMOSTASIS, 2015, 114 (02) : 440 - 444
  • [7] Reply to the article Non-VKA oral anticoagulants: an update for the clinical biologists
    Janus, Nicolas
    Aloy, Blandine
    Deray, Gilbert
    Launay-Vacher, Vincent
    ANNALES DE BIOLOGIE CLINIQUE, 2015, 73 (06) : 741 - 743
  • [8] Endomyocardial fibrosis and intracardiac thrombus occurring in idiopathic hypereosinophilic syndrome
    Salanitri, GC
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2005, 184 (05) : 1432 - 1433
  • [9] Drug interactions with oral anticoagulants in german nursing home residents-A comparison between vitamin K antagonists (VKA) and non-VKA oral anticoagulants
    Jobski, Kathrin
    Hoffmann, Falk
    Herget-Rosenthal, Stefan
    Doerks, Michael
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 10 - 10
  • [10] Bleeding Risk, Management and Outcome in Patients Receiving Non-VKA Oral Anticoagulants (NOACs)
    Sebastian Werth
    Tomás Breslin
    Fionnuala NiAinle
    Jan Beyer-Westendorf
    American Journal of Cardiovascular Drugs, 2015, 15 : 235 - 242